November 2, 2016
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
Chronix Biomedical looking to distinguish prostate cancer from BPH and prostatitis
Pharmaceuticals, Biotechnology and Life Sciences
Tag: cancer
November 1, 2016
Novartis gets FDA Priority Review for first-line treatment of advanced breast cancer
Novartis gets FDA Priority Review for first-line treatment of HR+/HER2-advanced breast cancer
October 26, 2016
AstraZeneca’s ovarian cancer tablets pass Phase III SOLO-2 trial
AstraZeneca’s Lynparza tablets against BRCA-mutated ovarian cancer have shown…
October 20, 2016
NCI picks ATCC to distribute tancer models for supporting human cancer models initiative
The National Cancer Institute (NCI) awarded ATCC, a global player in biological materials management and standards, a contract to distribute a new generation of …
October 19, 2016
Advandec Oncotherapy’s Harley Street site planning permission granted
Advanced Oncotherapy , the developer of proton therapy systems for cancer treatment, has announced on Tuesday that planning permission for the Harley Street site was granted.
October 11, 2016
Biocartis’ Idylla technology could enhance molecular diagnostic testing
Biocartis Group NV, a Belgian innovative molecular diagnostics company has published a comparative study organised by AstraZeneca where 12 different KRAS mutation detecting technologies, including Next-Generation Sequencing (NGS) and quantitative Polymerase Chain Reaction (PCR), were compared for the detection of KRAS mutations in lung cancer, using blinded samples.
October 9, 2016
No silver lining in failed Bristol cancer drug trail
Bristol-Myers Squibb disappointed investors on Sunday as researchers detailed data for its Opdivo cancer immunotherapy, which was already known to have failed to do better than older chemotherapies in a closely watched clinical trial.
November 30, 2015
DNA repair factor linked to breast cancer may also play a role in Alzheimer’s disease
Low levels of breast cancer factor 1 (BRCA1) protein in the brain may contribute to dementia, according to results of a National Institutes of Health (NIH)-funded study, published in Nature Communications.
November 30, 2015
Faron: Clevegen can be used as immunotherapy product
A publication on Clever-1 function related to Faron Pharmaceuticals’ novel cancer immunotherapy antibody Clevegen, was published in journal of the American Association of Immunology.
November 24, 2015
Bristol-Myres Squid’s Opdivo gets FDA’s nod (kidney cancer)
The U.S. Food and Drug Administration has approved Bristol-Myers Squibb-marketed Opdivo (nivolumab) to treat patients with advanced form of kidney cancer.